HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Beta-Blockers Hold No Mortality Benefit Following a Heart Attack

By HospiMedica International staff writers
Posted on 23 Nov 2014
Print article
A new study questions the contemporary management of myocardial infarction (MI) patients after hospital discharge with β-blockers.

Researchers at NYU Langone Medical Center (New York, NY, USA) and Mt. Sinai School of Medicine (New York, NY, USA) analyzed 60 randomized trials evaluating β-blockers use in MI. In all, 102,003 patients were included in the study, with 14 trials providing data on a follow-up longer than one year. The researchers evaluated the impact of contemporary treatment—reperfusion, aspirin, and statin—status on the association of early intravenous (IV) β-blocker use and outcomes in heart attack patients. The primary outcome was all-cause mortality.

The results showed that in acute MI, β-blockers reduced cardiovascular mortality, MI, and angina, in the pre-reperfusion era; there was no difference for other outcomes. In the reperfusion era, β-blockers reduced MI and angina, but at the expense of an increase in heart failure (HF) and cardiogenic shock, with no benefit for other outcomes. β-blockers held no mortality benefit in contemporary treatment of heart attacks. The study was published in the October 2014 issue of the American Journal of Medicine.

“In patients undergoing contemporary treatment, our data support the short-term [30 days] use of beta-blockers to reduce recurrent heart attacks and angina, but this has to be weighed at the expense of increase in HF, cardiogenic shock, and drug discontinuation, without prolonging life,” concluded lead author Sripal Bangalore, MD, MHA, of NYU Langone Medical Center, and colleagues. “The guidelines should reconsider the strength of recommendations for beta-blockers post myocardial infarction.”

β-blockers are used for the management of cardiac arrhythmias, protecting the heart from a second MI after a first heart attack (secondary prevention), and hypertension. They block the action of the endogenous catecholamines epinephrine and norepinephrine, in particular on adrenergic beta receptors located on cells of the heart muscles, airways, arteries, and other tissues that are part of the sympathetic nervous system. They also interfere with the binding to the receptor of other stress hormones, thus mediating the fight-or-flight response.

Related Links:

NYU Langone Medical Center
Mt. Sinai School of Medicine


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
12-Channel ECG
CM1200B
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Autoclavable Camera System
Precision AC

Print article

Channels

Surgical Techniques

view channel
Image: The Nami S miniaturized ultrasonic scalpel enables faster and safer RAS (Photo courtesy of Nami Surgical)

Miniaturized Ultrasonic Scalpel Enables Faster and Safer Robotic-Assisted Surgery

Robot-assisted surgery (RAS) has gained significant popularity in recent years and is now extensively used across various surgical fields such as urology, gynecology, and cardiology. These surgeries, performed... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more